je.st
news
Home
› ArcherDX To Collaborate With Illumina On Next-Generation Sequencing-Based In Vitro Diagnostics Development
ArcherDX To Collaborate With Illumina On Next-Generation Sequencing-Based In Vitro Diagnostics Development
2016-06-01 06:27:33| drugdiscoveryonline Home Page
ArcherDX, Inc. recently announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. Under terms of the agreement, ArcherDX will lead the development of a series of diagnostic tests utilizing ArcherDX’s Anchored Multiplex PCR (AMP) chemistry that will be run on the Illumina MiSeqDx instrument
Tags: development
vitro
diagnostics
collaborate
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||